Bausch + Lomb (BLCO) News Today $19.39 -0.16 (-0.82%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Brokerages Set Bausch + Lomb Co. (NYSE:BLCO) Price Target at $20.91November 21 at 4:35 AM | americanbankingnews.comLMR Partners LLP Sells 57,974 Shares of Bausch + Lomb Co. (NYSE:BLCO)LMR Partners LLP trimmed its position in Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 38.7% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 91,666 shares of the company's stock after selling 57,974 shares during the period. LMR Partners LLP's holdingNovember 19 at 5:36 AM | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Given Average Rating of "Moderate Buy" by AnalystsShares of Bausch + Lomb Co. (NYSE:BLCO - Get Free Report) have received an average rating of "Moderate Buy" from the twelve ratings firms that are presently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and seven have given a buy rating to thNovember 16, 2024 | marketbeat.comStrong Prescription Growth and Strategic Marketing Drive Bausch + Lomb’s Positive OutlookNovember 9, 2024 | markets.businessinsider.comRiver Road Asset Management LLC Acquires 85,987 Shares of Bausch + Lomb Co. (NYSE:BLCO)River Road Asset Management LLC boosted its holdings in Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 4.4% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,020,414 shares of the company's stock after buying an additional 85,987 shares duriNovember 5, 2024 | marketbeat.comFY2024 EPS Estimates for Bausch + Lomb Cut by HC WainwrightBausch + Lomb Co. (NYSE:BLCO - Free Report) - Stock analysts at HC Wainwright lowered their FY2024 EPS estimates for shares of Bausch + Lomb in a report issued on Thursday, October 31st. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings per share of $0.60 for the yeaNovember 4, 2024 | marketbeat.comBausch + Lomb (BLCO) Posts Impressive Revenue and Explores Potential SaleNovember 3, 2024 | msn.comBausch + Lomb Corporation (NYSE:BLCO) Q3 2024 Earnings Call TranscriptNovember 2, 2024 | msn.comBausch + Lomb (NYSE:BLCO) Price Target Raised to $24.00 at CitigroupCitigroup increased their price objective on shares of Bausch + Lomb from $20.00 to $24.00 and gave the company a "buy" rating in a research report on Thursday.October 31, 2024 | marketbeat.comBausch + Lomb’s Strong Financial Performance and Strategic Outlook Justify Buy Rating with $23 Price TargetOctober 31, 2024 | markets.businessinsider.comBausch + Lomb Sees Strong Growth in Q3 2024October 31, 2024 | markets.businessinsider.comShort Interest in Bausch + Lomb Co. (NYSE:BLCO) Grows By 5.6%Bausch + Lomb Co. (NYSE:BLCO - Get Free Report) was the recipient of a large increase in short interest in the month of October. As of October 15th, there was short interest totalling 1,520,000 shares, an increase of 5.6% from the September 30th total of 1,440,000 shares. Approximately 3.9% of the shares of the company are sold short. Based on an average trading volume of 744,500 shares, the days-to-cover ratio is currently 2.0 days.October 31, 2024 | marketbeat.comNeedham & Company LLC Reaffirms "Hold" Rating for Bausch + Lomb (NYSE:BLCO)Needham & Company LLC reissued a "hold" rating on shares of Bausch + Lomb in a research note on Thursday.October 31, 2024 | marketbeat.comBausch + Lomb Announces Third-Quarter 2024 ResultsOctober 31, 2024 | finanznachrichten.deBausch + Lomb Turns To Q3 Profit; Raises Full-year Revenue OutlookOctober 31, 2024 | markets.businessinsider.comBausch + Lomb Corporation (BLCO) Receives a Hold from NeedhamOctober 31, 2024 | markets.businessinsider.comBausch & Lomb Corp (TSX:BLCO) Q3 2024 Earnings Report Preview: What To Look ForOctober 30, 2024 | finance.yahoo.comPositive Prescription Growth and Strategic Confidence Drive Buy Rating for Bausch + LombOctober 28, 2024 | markets.businessinsider.comBausch Health price target raised to $10 from $8.50 at RBC CapitalOctober 24, 2024 | markets.businessinsider.comRBC erhöht Kursziel für Bausch & Lomb-Aktie vor Q3-ErgebnissenOctober 23, 2024 | de.investing.comBuy Rating Affirmed for Bausch + Lomb: Strong Q3 Performance and 2024 Sales OutlookOctober 23, 2024 | markets.businessinsider.comBausch + Lomb Corporation (BLCO) Receives a Buy from RBC CapitalOctober 23, 2024 | markets.businessinsider.comBausch + Lomb (NYSE:BLCO) PT Raised to $23.00Royal Bank of Canada upped their price objective on Bausch + Lomb from $20.00 to $23.00 and gave the company an "outperform" rating in a research note on Tuesday.October 22, 2024 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Given Average Rating of "Moderate Buy" by BrokeragesBausch + Lomb Co. (NYSE:BLCO - Get Free Report) has earned an average recommendation of "Moderate Buy" from the twelve brokerages that are covering the firm, MarketBeat reports. Five investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation toOctober 22, 2024 | marketbeat.comBausch Health Rejects Bondholders’ Debt Proposals, Explores Sale of Vision Care UnitOctober 18, 2024 | wsj.comBausch & Lomb shares upgraded, price target raisedOctober 17, 2024 | uk.investing.comBausch + Lomb (NYSE:BLCO) Shares Gap Up - Still a Buy?Bausch + Lomb (NYSE:BLCO) Shares Gap Up - Still a Buy?October 15, 2024 | marketbeat.comWells Fargo hält an Overweight-Einstufung für Bausch & Lomb-Aktien festOctober 15, 2024 | de.investing.comBausch & Lomb-Aktien hochgestuft, Kursziel angehobenOctober 15, 2024 | de.investing.comBausch + Lomb (NYSE:BLCO) Upgraded by Evercore ISI to "Outperform"Evercore ISI raised shares of Bausch + Lomb from an "in-line" rating to an "outperform" rating and upped their target price for the stock from $19.00 to $25.00 in a report on Tuesday.October 15, 2024 | marketbeat.comWhy Bausch + Lomb Stock Soared by Over 7% on MondayOctober 14, 2024 | fool.comBausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular LensOctober 14, 2024 | finance.yahoo.comFDA genehmigt neue Intraokularlinse von Bausch + LombOctober 14, 2024 | de.investing.comBausch + Lomb-Aktie erreicht 52-Wochen-Hoch bei 21,19 US-DollarOctober 14, 2024 | de.investing.comS&P 500 Futures Rise in Premarket Trading; Bausch + Lomb, MicroStrategy LeadOctober 14, 2024 | marketwatch.comBausch + Lomb : FDA Approves EnVista Envy Full Range Of Vision Intraocular LensOctober 14, 2024 | markets.businessinsider.comBausch + Lomb Stock Pops as TPG, Blackstone Consider Joint BidOctober 14, 2024 | investopedia.comBausch + Lomb (NYSE:BLCO) Reaches New 12-Month High - What's Next?Bausch + Lomb (NYSE:BLCO) Sets New 12-Month High - Here's WhyOctober 14, 2024 | marketbeat.comCubist Systematic Strategies LLC Invests $580,000 in Bausch + Lomb Co. (NYSE:BLCO)Cubist Systematic Strategies LLC acquired a new position in Bausch + Lomb Co. (NYSE:BLCO - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 39,916 shares of the company's stock, valued at aOctober 13, 2024 | marketbeat.comBausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30October 9, 2024 | finance.yahoo.comMarshall Wace LLP Makes New $1.91 Million Investment in Bausch + Lomb Co. (NYSE:BLCO)Marshall Wace LLP bought a new position in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 131,624 shares of the company's stock, valued at approximately $1,911,000. Other institutional investors andOctober 5, 2024 | marketbeat.comCubist Systematic Strategies LLC Makes New Investment in Bausch + Lomb Co. (NYSE:BLCO)Cubist Systematic Strategies LLC acquired a new position in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 39,916 shares of the company'October 4, 2024 | marketbeat.comBausch + Lomb price target raised to $19 from $17 at Evercore ISIOctober 2, 2024 | finance.yahoo.comBausch + Lomb Launches Opal™ Digital Marketplace in the United StatesOctober 1, 2024 | tmcnet.comBausch + Lomb Launches Opal(TM) Digital Marketplace in the United StatesOctober 1, 2024 | stockhouse.comPoint72 Asset Management L.P. Acquires 153,000 Shares of Bausch + Lomb Co. (NYSE:BLCO)Point72 Asset Management L.P. increased its stake in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 31.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 647,156 shares of the company's stock after acquiring anOctober 1, 2024 | marketbeat.comClearline Capital LP Acquires 411,404 Shares of Bausch + Lomb Co. (NYSE:BLCO)Clearline Capital LP raised its holdings in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 136.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 712,055 shares of the company's stock after buying anSeptember 29, 2024 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Receives Average Rating of "Moderate Buy" from AnalystsBausch + Lomb Co. (NYSE:BLCO - Get Free Report) has been given an average recommendation of "Moderate Buy" by the twelve research firms that are presently covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a hold recommendation and six have issued a buy recommSeptember 27, 2024 | marketbeat.comBausch Health: A Buyout Bid Could Be the Ticket to Unlock ValueThe potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.September 25, 2024 | marketbeat.comPoint72 Europe London LLP Buys 146,583 Shares of Bausch + Lomb Co. (NYSE:BLCO)Point72 Europe London LLP boosted its stake in Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 28.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 653,492 shares of the company's stock after purchasing anSeptember 25, 2024 | marketbeat.com Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. BLCO Media Mentions By Week BLCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCO News Sentiment▼0.840.45▲Average Medical News Sentiment BLCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCO Articles This Week▼34▲BLCO Articles Average Week Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zimmer Biomet News Today Solventum News Today Smith & Nephew News Today Penumbra News Today Glaukos News Today Inspire Medical Systems News Today PROCEPT BioRobotics News Today Axonics News Today Envista News Today Inari Medical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BLCO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch + Lomb Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch + Lomb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLCO Stock Alerts